Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Allogeneic bone marrow transplant in pediatric patients with high-risk hematopoietic malignancies early in the course of their disease.

Allogeneic bone marrow transplant in pediatric patients with high-risk hematopoietic malignancies early in the course of their disease. J Pediatr Hematol Oncol. 1997 Jan-Feb; 19(1):54-61.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.